site of action of vecuronium is
**Core Concept**
The site of action of vecuronium, a non-depolarizing neuromuscular blocker, is related to its mechanism of inhibiting **acetylcholine** receptors at the **neuromuscular junction**. This inhibition prevents **muscle contraction** and leads to muscle relaxation. Vecuronium acts by competing with **acetylcholine** for receptor sites.
**Why the Correct Answer is Right**
Vecuronium acts on the **nicotinic acetylcholine receptors** at the **neuromuscular junction**, which is the synapse between the terminal end of a motor neuron and a muscle fiber. By blocking these receptors, vecuronium prevents the binding of **acetylcholine**, thereby inhibiting **depolarization** of the muscle cell and subsequent **muscle contraction**.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because vecuronium's primary action is not on the muscle itself but on the receptors at the neuromuscular junction.
**Option B:** Incorrect as vecuronium does not act on the central nervous system to produce its muscle relaxant effects.
**Option C:** Incorrect because, although vecuronium is metabolized in the liver, its site of action is not there.
**Clinical Pearl / High-Yield Fact**
Vecuronium is often used in surgical procedures requiring muscle relaxation, and its effects can be monitored by assessing the degree of neuromuscular blockade, typically using a **train-of-four** stimulation pattern.
**Correct Answer:** D. neuromuscular junction.